Celgene signs cancer immunotherapy pacts with Kyn, Obsidian

The alliances come as its merger with Bristol-Myers Squibb progresses

Source: Chemical and Engineering News - January 23, 2019 Category: Chemistry Authors: Lisa M. Jarvis Source Type: research